Angiotensin-converting enzyme inhibitors in patients with coronary atherosclerosis
- 1 December 1994
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 128 (6) , 1328-1332
- https://doi.org/10.1016/0002-8703(94)90255-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathyThe Lancet, 1993
- Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarctionThe Lancet, 1993
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with HypertensionNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987